Remarkably, while the antitumor effects of anti-Gal-9 or anti-GITR alone were transient and modest, their combination synergistically suppressed tumor growth and prolonged overall survival (Fig. 5a–c; Supplementary Fig. 4a, b). The gene discussed is LGALS9; the disease is neoplasm.